TRIM44 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.807600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.328800E-01
Normal-vs-Stage2
2.025600E-01
Normal-vs-Stage3
1.527230E-01
Normal-vs-Stage4
9.250000E-01
Stage1-vs-Stage2
7.363400E-01
Stage1-vs-Stage3
9.456200E-02
Stage1-vs-Stage4
3.662800E-01
Stage2-vs-Stage3
3.236200E-03
Stage2-vs-Stage4
9.967900E-02
Stage3-vs-Stage4
9.955900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.601970E-01
Normal-vs-AfricanAmerican
8.620200E-01
Normal-vs-Asian
8.614000E-02
Caucasian-vs-AfricanAmerican
1.334640E-01
Caucasian-vs-Asian
2.525200E-01
AfricanAmerican-vs-Asian
1.106440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.880420E-01
Normal-vs-Female
1.934370E-01
Male-vs-Female
9.879000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.035600E-01
Normal-vs-Age(41-60Yrs)
4.867000E-01
Normal-vs-Age(61-80Yrs)
9.357500E-02
Normal-vs-Age(81-100Yrs)
8.450100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.477200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.993400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.832600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.309600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.796400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.080600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.428000E-02
Normal-vs-Daily Drinker
2.644500E-02
Normal-vs-Weekly Drinker
6.180500E-02
Normal-vs-Occasional Drinker
4.719600E-01
Normal-vs-Social Drinker
5.164800E-01
Non Drinker-vs-Daily Drinker
2.422200E-01
Non Drinker-vs-Weekly Drinker
5.740400E-01
Non Drinker-vs-Occasional Drinker
2.120000E-01
Non Drinker-vs-Social Drinker
1.649970E-01
Daily Drinker-vs-Weekly Drinker
6.775600E-01
Daily Drinker-vs-Occasional Drinker
4.670200E-02
Daily Drinker-vs-Social Drinker
3.000000E-02
Weekly Drinker-vs-Occasional Drinker
1.597430E-01
Weekly Drinker-vs-Social Drinker
1.127780E-01
Occasional Drinker-vs-Social Drinker
8.719400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.256800E-01
Normal-vs-Grade 2
1.120010E-01
Normal-vs-Grade 3
4.925700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.897200E-01
Grade 1-vs-Grade 3
8.766000E-02
Grade 1-vs-Grade 4
2.256800E-01
Grade 2-vs-Grade 3
2.211200E-01
Grade 2-vs-Grade 4
1.120010E-01
Grade 3-vs-Grade 4
4.925700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.762300E-02
Normal-vs-NonDiabetic
9.739900E-02
Diabetic-vs-NonDiabetic
8.826600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.614800E-01
Normal-vs-NoPancreatitis
1.166420E-01
Pancreatitis-vs-NoPancreatitis
2.673000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.903610E-01
Normal-vs-N1
2.039400E-01
N0-vs-N1
5.713200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.928000E-01
Normal-vs-TP53-NonMutant
3.701800E-01
TP53-Mutant-vs-TP53-NonMutant
8.213600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
